Skip to main content
Clinical Trials/NCT00569413
NCT00569413
Suspended
N/A

A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality

Hadassah Medical Organization0 sites40 target enrollmentApril 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hypoactive Sexual Desire Disorder
Sponsor
Hadassah Medical Organization
Enrollment
40
Primary Endpoint
Brain Imaging data of DRD2 receptor occupancy during watching a sex videotape and neutral videotape
Status
Suspended
Last Updated
15 years ago

Overview

Brief Summary

The current study combines a molecular genetic perspective, self report and brain imaging to the study of human sexuality in control subjects and individuals from a sexual disorder clinic. The investigators hypothesize that the variability in components of the brain dopaminergic system expressed in the mesolimbic reward system can explain variability in human sexuality, especially in desire and pleasure associated with sex.

Detailed Description

We intend to combine molecular genetics of the dopamine receptors (D2, D3 D4 and D5) and brain imaging using 11 C Raclopride in Positron Emission Tomography (PET). 11 C Raclopride is a ligand which binds to the dopamine receptor D2 and can measure dopamine release during pleasure or anticipatory reward associated with sex. The current proposal will measure changes in DRD2 receptor occupancy using 11 C Raclopride following explicit visual sexual desire cues in healthy control subjects and individuals who suffer from sexual dysfunction. This is in order to determine how individual genotypes modulate dopamine release in vivo in the human brain.

Registry
clinicaltrials.gov
Start Date
April 2011
End Date
October 2011
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy volunteers and patients
  • Age 21-65
  • Male or female

Exclusion Criteria

  • Psychiatric diagnosis/psychosis
  • Neurological damage associated with loss of consciousness
  • Infectious disease HIV
  • Hyperactivity treated with ritalin
  • Pregnant women
  • Under age

Outcomes

Primary Outcomes

Brain Imaging data of DRD2 receptor occupancy during watching a sex videotape and neutral videotape

Time Frame: 2 Brain imaging sessions a week apart

Secondary Outcomes

  • Questionnaire ratings of human sexuality, pleasure, and anticipatory reward(Taken during brain scans)

Similar Trials